Skip to content
Article Rich – Lifestyle
Author:
SOLIGENIX, INC.
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
March 10, 2026
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet’s Disease
March 5, 2026
←
Previous Page
1
2